Latest treatment of cancer Stories
TSX Venture: QPT EDMONTON, Jan. 13, 2015 /PRNewswire/ - Quest PharmaTech Inc.
SCIB1 continues to generate highly encouraging survival data; Modi-1 vaccine on track for 2016 entry into clinic NOTTINGHAM, England, December 10, 2014 /PRNewswire/ --
TSX Venture: QPT EDMONTON, Oct. 22, 2014 /PRNewswire/ - Quest PharmaTech Inc.
$1.5 million in proceeds to fund 2014 commencement of HPPI's clinical development program for repurposing the approved anti-fungal drug itraconazole for the treatment of cancer, initially for the treatment
BREDA, the Netherlands, GHENT, Belgium and WHITE PLAINS, New York, June 10, 2014 /PRNewswire/ -- arGEN-X, a clinical stage biopharmaceutical company focused on creating
Gallus BioPharmaceuticals, LLC, a premier pure-play biologics contract manufacturing organization has signed a manufacturing agreement with Symphogen, A/S, a private biopharmaceutical company
DURHAM, N.C., Jan.
- A political dynamiter.